Genetic and morphological markers are well-established prognostic factors in acute myeloid
leukemia (AML). However, further reliable markers are urgently needed to improve risk …

We estimated by quantitative flow cytometry (FC) the expression of CD13, CD33, CD34 and
CD117 antigens in cells from 64 patients with acute myeloid leukaemia (AML) and 22 …

Abstract CUB‐domain‐containing protein 1 (CDCP1) is a novel transmembrane molecule
that is expressed in metastatic colon and breast tumors as well as on the surface of …

Objective Cell division control protein 42 (CDC42) induces the immune escape, represses
the CD8+ T‐cell activation, and further leads to the tumor metastasis in various neoplasms …

Cell division cycle 25 (CDC25) protein phosphatases regulate cell cycle progression
through the activation of cyclin-dependent kinases (CDKs), but they are also involved in …

In many cancers, cells undergo re-programming of metabolism, cell survival and anti-
apoptotic defense strategies, with the proteins mediating this reprogramming representing …

Among other phenotypic markers, CD11b expression has been considered as an
unfavorable prognostic factor, both in terms of overall survival (OS), disease-free survival …

Background Cell division control protein 42 (CDC42) is involved in colorectal cancer (CRC)
progression by modulating CD8+ T cell activation, immune escape, and direct oncogenetic …

Recently, an international collaboration collected information from; 3500 chronic lymphocytic
leukemia (CLL) patients to develop a comprehensive tool for predicting overall survival …

Background We studied the expression of CD200 in a series of 101 patients with diagnosis
of myelodysplastic syndrome (MDS), to evaluate its impact on outcome and its possible …